Imidazopyridine derivatives as angiotensin II receptor antagonis

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

546118, A61K 31535, A61K 31435, C07D47104

Patent

active

054440688

ABSTRACT:
Imidazo-fused iso- and heterocycles, process for their preparation, compositions containing them and their use
A compound of the formula ##STR1## in which the symbols have the following meaning: X is a monocyclic radical having 3,4 or 5 ring atoms,

REFERENCES:
patent: 4594421 (1986-06-01), Bellani et al.
patent: 4612323 (1986-09-01), Kisida et al.
patent: 4663339 (1987-05-01), Kisida et al.
patent: 4880804 (1989-11-01), Carini et al.
patent: 4987145 (1991-01-01), Kisida et al.
patent: 5021443 (1991-06-01), Bru-Magniez et al.
patent: 5087702 (1992-02-01), Chen et al.
patent: 5102880 (1992-04-01), Chakravarty et al.
patent: 5128356 (1992-06-01), Naka et al.
patent: 5158327 (1992-07-01), Chakravarty et al.
patent: 5177074 (1993-01-01), Allen et al.
patent: 5223499 (1993-06-01), Greenlee et al.
Derwent Abstract DE 40 25 358 A1 (1993).
Derwent Abstract Japanese Patent No. 4 235973 (1993).
Derwent Abstract EP 0 420 237 (1993).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Imidazopyridine derivatives as angiotensin II receptor antagonis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Imidazopyridine derivatives as angiotensin II receptor antagonis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazopyridine derivatives as angiotensin II receptor antagonis will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2142029

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.